Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China

Condition:   Hyperphosphatemia Interventions:   Drug: Placebo;   Drug: Sevelamer Carbonate (GZ419831) Sponsor:   Sanofi Not yet recruiting - verified December 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials